Liquidia Corporation (LQDA) stock analysis

In our weekly check, Liquidia Corporation is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 14 pass, warnings: 0, red flags: 8.

About Liquidia Corporation

Liquidia Corporation is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as LQDA.

What our checks show for LQDA

Red flags

Strengths

Similar companies

KNSA · CORT · RPRX

Questions

What grade does Liquidia Corporation (LQDA) have?

In our weekly check, Liquidia Corporation is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 14 pass, warnings: 0, red flags: 8. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of LQDA stock?

This week's biggest flags for Liquidia Corporation: Weak interest cover, Weak EPS growth, Thin margins. In total 8 of 22 checks show a warning or a red flag.

What does Liquidia Corporation do?

Liquidia Corporation is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as LQDA.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis